Wildcat Capital Management, LLC
CIK 1582384 · View on SEC EDGAR ↗
- Portfolio value
- $228.5M
- Positions
- 3
- As of
- June 30, 2026
Portfolio value QoQ: +115.2% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $488,940 · sells $0
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 25.0% still held
- New positions
- 1
- Increased
- 0
- Decreased
- 0
- Closed
- 1
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +19.6% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.8% · Options excluded: 0.0%
Sector breakdown
Full portfolio 3 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| ULCC Frontier Group Holdings, Inc. - Common Stock | $221,965,286 | 97.13% | 28,061,351 | $122,908,717 | |||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $6,075,237 | 2.66% | 2,920,787 | $-1,051,483 | |||
| CHYM Chime Financial, Inc. - Class A Common Stock | $488,940 | 0.21% | 23,874 | Up ×1 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| CHYM | $488,940 | 23,874 | 0.21% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| RLX | Dec. 31, 2025 | 6,418,183 | $16,879,821 | -21.5% |
| TIC | Sept. 30, 2025 | 1,500,000 | $16,560,000 | -28.6% |
| URGN | Sept. 30, 2025 | 495,606 | $6,789,802 | 131.9% |
| CNTA | June 30, 2025 | 281,859 | $4,053,132 | No longer tracked |
| KRON | June 30, 2025 | 1,297,959 | $1,070,816 | No longer tracked |
| GTLB | March 31, 2025 | 11,399 | $642,334 | -13.0% |
| PCOR | March 31, 2025 | 8,095 | $606,558 | -5.8% |
| TTAN | Dec. 31, 2025 | 4,138 | $417,235 | -14.3% |
| PCOR | March 31, 2026 | 3,851 | $280,122 | 9.2% |
| GTLB | Dec. 31, 2025 | 5,861 | $264,214 | 8.9% |
| SLXN | Sept. 30, 2025 | 113,428 | $91,877 | -88.5% |